GENETIC EPIDEMIOLOGY OF ALZHEIMER'S DISEASE IN TWINS
Project Number3R01AG008549-10S2
Contact PI/Project LeaderPLASSMAN, BRENDA L
Awardee OrganizationDUKE UNIVERSITY
Description
Abstract Text
DESCRIPTION: (Adapted from the Investigator's Abstract) The National Academy of
Sciences/National Research Council Twin Registry ("the Registry") contains
approximately 4,300 living pairs of white male twins who will be aged 72-83 in
2000. This competing renewal application proposes studies in the Registry that,
combined with work to date, will yield 240 twin pairs in which one or both
members have Alzheimer's disease (AD). This population-based panel will enable
the continued investigation of four broad aims: 1) Estimate the magnitude of
genetic influences on the development and age of onset of AD by contrasting
concordance rates and the similarity of onsets within monozygotic (MZ) and
dizygotic (DZ) pairs; 2) Characterize the environmental contribution of
variability of onset of AD. For example, variability of onset within MZ pairs
defines the maximum degree to which the environmental influences can modify the
onset of AD; 3) Evaluate the role of specific genes on the development and age
of onset of AD using the Sibling Transmission/Disequilibrium Test approach to
investigate the association between candidate genes such as alpha-2
macroglobulin (A2M) and AD; and 4) Identify environmental factors that are
associated with the risk of developing AD, using the co-twin control method.
The research will capitalize upon recent developments in the genetics of AD,
specifically the influence of apolipoprotein E (APOE) genotype and candidate
gene A2M on both liability to AD and its timing of onset. Such findings can be
used to refine the classical twin paradigm of investigating broad (but
heterogeneous) genetic and environmental influences. Thus, one can not only
estimate the heritability of AD in general, but also undertake partitioned
analyses to estimate the phenotypic variance attributable to genotypes at APOE
or other marker systems, as these are identified. However, until all of the
genes that predispose to AD are identified, the twin method has several
advantages over other approaches in identifying the extent of the genetic and
environmental contribution to AD.
Several MZ twin pairs have been described with widely divergent onsets of AD.
Environmental factors may therefore alter the onset, and hence the populations
risk, of some genetically defined forms of AD. This study will analyze the
environmental contribution to variability of onset, and will characterize the
divergence in onset within sets of genetically matched individuals. Since
comprehensive information on environmental factors has been collected on all
participating members of the twin registry, this study will also employ the
co-twin control method to seek the specific environmental factors that may be
responsible for this variation. A population-based twin design remains the
ideal approach to these sorts of investigations.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Alzheimer's diseaseapolipoprotein Eclinical researchdisease /disorder etiologydisease /disorder onsetdisease /disorder proneness /riskdizygotic twinsfamily geneticsgene environment interactiongenetic registry /resource /referral centergenetic susceptibilityhuman genetic material taghuman old age (65+)human subjectlongitudinal human studylow density lipoprotein receptormacroglobulinsmalemonozygotic twinspatient /disease registrystatistics /biometrytwin /multiplet
No Sub Projects information available for 3R01AG008549-10S2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01AG008549-10S2
Patents
No Patents information available for 3R01AG008549-10S2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01AG008549-10S2
Clinical Studies
No Clinical Studies information available for 3R01AG008549-10S2
News and More
Related News Releases
No news release information available for 3R01AG008549-10S2
History
No Historical information available for 3R01AG008549-10S2
Similar Projects
No Similar Projects information available for 3R01AG008549-10S2